Йовесто
Основна информация
- Търговско наименование:
- Йовесто 0,5 mg/ml перорален разтвор
- Активна съставка:
- Дезлоратадин
- Предлага се от:
- Sandoz d.d.
- АТС код:
- R06AX27
- INN (Международно Name):
- Desloratadine
- Използвай за:
- Хората
- Вид на лекарството:
- алопатични наркотици
Документи
- за широката общественост:
- Листовка за пациента
-
- за медицински специалисти:
- кратка характеристика на продукта
-
Локализация
- Предлага се в:
-
България
- Език:
- български
Терапевтична информация
- Каталог на резюме:
- Jovesto, 0,5 mg/ml oral solution 1 x 60 ml; 1 x 120 ml; 1 x 150 ml
Друга информация
Състояние
- Източник:
- Изпълнителна агенция по лекарствата - Bulgarian Drug Agency - Bulgaria
- Номер на разрешението:
- 20120370
- Дата Оторизация:
- 13-11-2014
- Последна актуализация:
- 01-06-2018
Листовка за пациента: състав, показания, Нежелани лекарствени реакции, дозиране, взаимодействия, бременност, кърмене
- Достъпът до този документ е достъпен само за регистрирани потребители.
Регистрирайте се сега за пълен достъп
7-8-2018
Human medicines European public assessment report (EPAR): Azomyr, desloratadine, Revision: 42, Authorised
Europe - EMA - European Medicines Agency
18-7-2018
Human medicines European public assessment report (EPAR): Aerinaze, desloratadine / pseudoephedrine, Revision: 16, Authorised
Europe - EMA - European Medicines Agency
10-7-2018
Human medicines European public assessment report (EPAR): Aerius, desloratadine, Revision: 41, Authorised
Europe - EMA - European Medicines Agency
22-6-2018
Human medicines European public assessment report (EPAR): Neoclarityn, desloratadine, Revision: 37, Authorised
Europe - EMA - European Medicines Agency
23-5-2018
Human medicines European public assessment report (EPAR): Desloratadine Teva, desloratadine, Revision: 12, Authorised
Europe - EMA - European Medicines Agency
14-12-2018
Desloratadine Teva (Teva B.V.)
Desloratadine Teva (Active substance: desloratadine) - Centralised - Yearly update - Commission Decision (2018)8912 of Fri, 14 Dec 2018
Europe -DG Health and Food Safety
14-11-2018
Desloratadine ratiopharm (ratiopharm GmbH)
Desloratadine ratiopharm (Active substance: desloratadine) - Centralised - Yearly update - Commission Decision (2018)7603 of Wed, 14 Nov 2018
Europe -DG Health and Food Safety
3-7-2018
Aerius (Merck Sharp and Dohme B.V.)
Aerius (Active substance: desloratadine) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018) 4255 of Tue, 03 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/313/T/90
Europe -DG Health and Food Safety
3-7-2018
Azomyr (Merck Sharp and Dohme B.V.)
Azomyr (Active substance: desloratadine) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018) 4253 of Tue, 03 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/310/T/94
Europe -DG Health and Food Safety
19-6-2018
Aerinaze (Merck Sharp and Dohme Limited)
Aerinaze (Active substance: desloratadine; pseudoephedrine sulphate) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)3930 of Tue, 19 Jun 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/772/T/37
Europe -DG Health and Food Safety
19-6-2018
Neoclarityn (Merck Sharp and Dohme Limited)
Neoclarityn (Active substance: desloratadine) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)3931 of Tue, 19 Jun 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/314/T/88
Europe -DG Health and Food Safety